Evaluation of the safety and tolerability of neoral and sandimmune: a meta-analysis

By Shah M.B.   Martin J.E.   Schroeder T.J.   First M.R.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1697-1700

Elsevier

Access to resources Recommend Favorite

Safety of conversion from cyclosporine sandimmune to cyclosporine neoral in stable liver transplant patients

By Baruch Y.   Assy N.   Kramsky R.   Enat R.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1852-1853

Elsevier

Access to resources Recommend Favorite

Validity of open labeled versus blinded trials: a meta-analysis comparing neoral and sandimmune

By Shah M.B.   Martin J.E.   Schroeder T.J.   First M.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 217-219

Elsevier

Access to resources Recommend Favorite

Conversion From Cyclosporine Sandimmune to Cyclosporine Neoral in the Stable Renal Transplant Population

By Griffin P.J.A.   Moore R.H.   Jurewicz W.A.   Lord R.H.H.   Webley Y.   Jenkins J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 303-303

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients

By Fisher R.A.   Pan S.-H.   Rossi S.J.   Schroeder T.J.   Irish W.D.   Canafax D.M.   Lopez R.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 394-395

Elsevier

Access to resources Recommend Favorite